Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2024279238-A1 · Aug 22, 2024 · US
This page is not indexed by search engines while we improve data quality.
Johns Brian A patents
Johns Brian A is listed as an inventor on 21 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Johns Brian A |
| Total patents | 21 |
| First publication | Jun 9, 2015 |
| Latest publication | Aug 22, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
SUBSTITUTED 1,2,3,3a,4,5,7,9,13,13a-DECAHYDROPYRIDO[1',2':4,5]PYRAZINO[1,2-a]PYRROLO[1,2-c]PYRIMIDINES HAVING HIV INTEGRASE INHIBITORY ACTIVITY
US-2022213121-A1 · Jul 7, 2022 · US
Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1′,2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity
US-11267823-B2 · Mar 8, 2022 · US
N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activity
US-10927129-B2 · Feb 23, 2021 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2020339598-A1 · Oct 29, 2020 · US
N-[(2,4-DIFLUOROPHENYL)METHYL]-6-HYDROXY-3-METHYL-5,7-DIOXO-2,3,5,7,11,11a-HEXAHYDRO[1,3]OXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINE-8-CARBOXAMIDE HAVING HIV INTEGRASE INHIBITORY ACTIVITY
US-2019284208-A1 · Sep 19, 2019 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2019152990-A1 · May 23, 2019 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017369509-A1 · Dec 28, 2017 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017267693-A1 · Sep 21, 2017 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017260203-A1 · Sep 14, 2017 · US
Recent patents
Latest publications not already listed above.
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017253616-A1 · Sep 7, 2017 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017224695-A1 · Aug 10, 2017 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017224694-A1 · Aug 10, 2017 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017209454-A1 · Jul 27, 2017 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017145033-A1 · May 25, 2017 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2017029438-A1 · Feb 2, 2017 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2016304535-A1 · Oct 20, 2016 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2016207939-A1 · Jul 21, 2016 · US
Substituted pyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitors
US-9273065-B2 · Mar 1, 2016 · US
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
US-2015232479-A1 · Aug 20, 2015 · US
Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamides
US-9051337-B2 · Jun 9, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Shionogi & Co | 20 |
| Viiv Healthcare Co | 19 |
| Viiv Healthcare Co | 2 |
| Shinogi Co | 1 |
| Shionogi & Co | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.